HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of HIF-1-active cells in angiogenesis and radioresistance.

Abstract
Human solid tumors contain hypoxic regions that have considerably lower oxygen tension than the normal tissues. Hypoxia offers resistance to radiotherapy and anticancer chemotherapy, as well as predispose to increased tumor metastases. Furthermore, hypoxia induces hypoxia-inducible factor-1 (HIF-1), which in turn increases tumor angiogenesis. Thus, eradication of HIF-1-active/hypoxic tumor cells is very important for cancer therapy. We have previously reported that procaspase-3 fused with a von Hippel-Lindau (VHL)-mediated protein destruction motif of alpha subunit of HIF-1 (HIF-1alpha) containing Pro564, named TAT-ODD-procaspase-3 (TOP3), specifically induced cell death to hypoxic cells in vivo as well as in vitro. We now report that TOP3 also eradicates the radiation-induced HIF-1-active tumor cells. HIF-1 activity in the xenografts of human tumor cells, which express luciferase under the transcriptional control of HIF-1, were monitored and quantified daily with an in vivo bioluminescence photon-counting device. HIF-1 activity in tumors was more rapidly increased by ionizing radiation (IR) compared to untreated tumors. TOP3 efficiently decreased the HIF-1-activity in irradiated tumors as well as unirradiated ones, indicating TOP3 eradicated tumor cells with HIF-1-activity induced by IR as well as hypoxia. Eradication of HIF-1-active/hypoxic cells in the xenografts during irradiation exhibited significant suppression in angiogenesis and strong enhancement in a long-term growth suppression of tumor xenografts. These results further strengthen the argument that HIF-1-active/hypoxic cells play crucial roles in angiogenesis and radioresistance.
AuthorsH Harada, S Kizaka-Kondoh, G Li, S Itasaka, K Shibuya, M Inoue, M Hiraoka
JournalOncogene (Oncogene) Vol. 26 Issue 54 Pg. 7508-16 (Nov 29 2007) ISSN: 1476-5594 [Electronic] England
PMID17563752 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Recombinant Fusion Proteins
  • TOP3 fusion protein
Topics
  • Adenocarcinoma (pathology, physiopathology, prevention & control)
  • Animals
  • Cell Death
  • Cell Hypoxia
  • Cell Line, Tumor
  • Female
  • HeLa Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (deficiency, genetics, physiology, radiation effects)
  • Mice
  • Mice, Transgenic
  • Neovascularization, Pathologic (prevention & control)
  • Pancreatic Neoplasms (pathology, physiopathology, prevention & control)
  • Promoter Regions, Genetic
  • Radiation, Ionizing
  • Recombinant Fusion Proteins (physiology)
  • Transplantation, Heterologous
  • Uterine Cervical Neoplasms (pathology, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: